Market cap
$642.7M
Shares out
21.0M

Surrozen Inc. (SRZN) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 19 wire items for SRZN, including 7 13D/G filings, 6 SEC filings and 3 press releases and news items. The most recent was published Nov 18, 2026.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are highly expressed in intestinal crypts. The company was founded in 2016 and is headquartered in South San Francisco, California.

SRZN rankings

Financial highlights

Full financials
Revenue, TTM
$10.53M
Revenue growth
+192.1%
Net income, TTM
-$390.21M
Net margin
-3706.4%
Free cash flow, TTM
-$30.77M
Cash
$100.35M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks36+129%
2026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 42026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 12026-07-19: 12026-07-26: 02026-08-02: 42026-08-09: 02026-08-16: 12026-08-23: 02026-08-30: 12026-09-06: 12026-09-13: 02026-09-20: 02026-09-27: 22026-10-04: 02026-10-11: 02026-10-18: 52026-10-25: 02026-11-01: 22026-11-08: 62026-11-15: 8
2026-05-242026-11-15
Mix2590d
  • SEC Filings8(32%)
  • 13D/G7(28%)
  • Other6(24%)
  • Insider2(8%)
  • Offering1(4%)
  • Earnings1(4%)
Activity · 52 weeks9952 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

SRZN FAQ

10 questions
  • What does Surrozen Inc. do?
    Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific...
  • What is the latest news on SRZN?
    In the last 30 days Quantisnow tracked 19 wire items for SRZN: 7 13D/G filings, 6 SEC filings, 3 press releases and news items and 2 insider trades. The most recent was published on November 18, 2026.
  • What is SRZN revenue?
    Surrozen Inc. (SRZN) reported $10.53M of revenue for the twelve months ended Sep 30, 2026. That is up 192.1% from the year before. Revenue for fiscal 2025 was $3.48M.
  • Is SRZN profitable?
    No. Surrozen Inc. reported a net loss of $390.21M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does SRZN have?
    Surrozen Inc. reported $100.35M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does SRZN stock trade?
    Surrozen Inc. (SRZN) is listed on NASDAQ.
  • What sector and industry is SRZN in?
    Surrozen Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • What are analysts saying about SRZN?
    Across the last 8 analyst actions on Surrozen Inc., there was 1 upgrade and 0 downgrades. The most recent action was from William Blair: Outperform with a $51.00 price target on 2026-08-20. Recent price targets range from $11.00 to $51.00.
  • What companies are similar to SRZN?
    Notable peers in the same industry include RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.), AMGN (Amgen Inc.). Compare SRZN side-by-side with any of them on Quantisnow.
  • How can I track SRZN on Quantisnow?
    Quantisnow aggregates Surrozen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SRZN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change